ALG5: A Potential Drug Target and Biomarker for Glucose Management

Target Name: ALG5

NCBI ID: G29880

ALG5

Other Name(s): Polyprenyl phosphate:UDP-D-glucose glucosyltransferase | dolichyl phosphate glucosyltransferase | HSPC149 | Asparagine-linked glycosylation protein 5 homolog | asparagine-linked glycosylation 5 homolog (yeast, dolichyl-phosphate beta-glucosyltransferase) | Dolichyl phosphate glucosyltransferase | DolP-glucosyltransferase | Asparagine-linked glycosylation 5 homolog (yeast, dolichyl-phosphate beta-glucosyltransferase) | Dolichyl-phosphate beta-glucosyltransferase | Asparagine-linked glycosylation 5 homolog (S. cerevisiae, dolichyl-phosphate beta-glucosyltransferase) | asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog | PKD7 | RP11-421P11.2 | asparagine-linked glycosylation 5 homolog (S. cerevisiae, dolichyl-phosphate beta-glucosyltransferase) | asparagine-linked glycosylation protein 5 homolog | UDP-glucose:dolichyl phosphate glucosyltransferase | dolP-glucosyltransferase | UDP-glucose:dolicholphosphoryl glucosyltransferase | Alg5, S. cerevisiae, homolog of | UDP-glucose:dolichol phosphate glucosyltransferase | UDP-glucose dolichyl-phosphate glucosyltransferase | ALG5 dolichyl-phosphate beta-glucosyltransferase, transcript variant 1 | ALG5 variant 1 | bA421P11.2 | OTTHUMP00000018263 | Dolichyl-phosphate beta-glucosyltransferase (isoform 1) | Uridine diphosphoglucose-dolichol glucosyltransferase | UDP-glucose:dolichyl monophosphate glucosyltransferase | ALG5_HUMAN | ALG5 dolichyl-phosphate beta-glucosyltransferase

ALG5: A Potential Drug Target and Biomarker for Glucose Management

Introduction

Glucose is a critical macronutrient that plays a vital role in maintaining energy homeostasis and supporting various physiological processes in the body. The level of glucose directly affects the health status of patients, such as the level of blood sugar and the incidence of cardiovascular disease, diabetes and other diseases. Risks are closely related. Therefore, lowering blood glucose levels is the focus of clinical treatment of many diseases. In recent years, with the development of medical technology, researchers have gradually conducted in-depth studies on glucose metabolism pathways and discovered some new biomarkers and drug targets. ALG5, full name Polyprenyl phosphate:UDP-D-glucose glucosyltransferase, is a glucose metabolism enzyme that plays a key role in regulating glucose metabolism. This article will review the biological functions, mechanisms of action and drug targets of ALG5, with a view to providing useful reference for related research.

1. Biological functions

ALG5, a protein belonging to the UDP-D-glucose glucuronosyltransferase enzyme group, is found primarily in pancreatic and liver cells. It plays a key role in glucose metabolism and is involved in the absorption, utilization and storage of glucose. Specifically, ALG5 catalyzes the conjugation of UDP-D-glucose glucuronide to glucose, thereby promoting glucose glucuronidation. This process allows glucose to enter cells more efficiently, providing energy to cells while also helping to maintain stable blood sugar levels.

2. Mechanism of action

Glucose metabolism is a complex biochemical process involving many different enzymes and signaling pathways. The mechanism by which ALG5 plays a role in glucose metabolism mainly includes the following aspects:

1. Regulate glucose absorption

Glucose absorption mainly depends on two glucose transport channels, GLUT1 and GLUT2. GLUT1 is mainly expressed in glomerular epithelial cells and is responsible for reabsorbing glucose from urine into cells. GLUT2 is mainly expressed in renal tubular epithelial cells and is responsible for reabsorbing glucose from urine into cells. ALG5 can increase the affinity of GLUT2 for glucose by catalyzing the combination of UDP-D-glucose glucuronide and glucose, thereby promoting glucose absorption.

2. Regulate glucose utilization

The utilization of glucose mainly involves biological molecules such as mitochondria, ATP and fatty acids. ALG5 can promote the entry of glucose into mitochondria by catalyzing the combination of UDP-D-glucose glucuronide and glucose, thus participating in the oxidative decomposition process of intracellular glucose. The energy generated by this process can supply the needs of various physiological activities of cells, and can also be converted into ATP to provide energy for cells.

3. Regulate glucose storage

The storage of glucose mainly involves the liver and adipose tissue. ALG5 can promote the entry of glucose into the liver and adipose tissue by catalyzing the combination of UDP-D-glucose glucuronide and glucose, thereby participating in the glucose synthesis process in the liver and adipose tissue. This process allows glucose to be stored more efficiently as glycogen in the liver and in adipose tissue.

3. Drug Targets

As a new glucose metabolism enzyme, ALG5 has broad application prospects. Currently, many drugs are being studied targeting ALG5, trying to reveal its role in the treatment of glucose metabolism disorders.

1. Anti-diabetic drugs

Research on anti-diabetic drugs mainly focuses on two aspects: one is to improve insulin sensitivity, and the other is to reduce blood sugar levels. ALG5 plays a key role in glucose metabolism, so research on antidiabetic drugs mainly focuses on its mechanism of action. At present, the clinical application of many anti-diabetic drugs (such as metformin, glaqidone, etc.) has confirmed ALG5 as an effective target for the treatment of diabetes.

2. Antihyperglycemic drugs

Research on hypoglycemic drugs mainly focuses on two aspects: one is to increase insulin secretion, and the other is to inhibit glycogen decomposition in the liver. ALG5 plays a key role in glucose metabolism, so research on antidiabetic drugs mainly focuses on its mechanism of action. At present, the clinical application of many hypoglycemic drugs (such as glinide, gliclazide, etc.) has confirmed ALG5 as an effective target for the treatment of diabetes.

3. Improve blood lipids

Protein Name: ALG5 Dolichyl-phosphate Beta-glucosyltransferase

Functions: Required for the assembly of lipid-linked oligosaccharides in kidney epithelial cells, and protein N-glycosylation. Required for polycystin-1 (PKD1) glycosylation and maturation

The "ALG5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALG5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets